Skip to Content

Russell Inv Equity Income C REQSX

Medalist Rating as of | See Russell Investments Investment Hub
  • NAV / 1-Day Return 24.57  /  +1.28 %
  • Total Assets 189.5 Mil
  • Adj. Expense Ratio
    1.870%
  • Expense Ratio 1.870%
  • Distribution Fee Level Above Average
  • Share Class Type Level Load
  • Category Large Value
  • Investment Style Large Value
  • Min. Initial Investment
  • Status Open
  • TTM Yield 0.63%
  • Turnover 31%

USD | NAV as of Jul 26, 2024 | 1-Day Return as of Jul 26, 2024, 11:00 PM GMT+0

Morningstar’s Analysis REQSX

Will REQSX outperform in future?

Get our overall rating based on a fundamental assessment of the pillars below.

The combination of a middling Process Pillar rating and a Low People Pillar rating limit Russell Inv Equity Income C to a Morningstar Medalist Rating of Negative.

null Morningstar Manager Research

Morningstar Manager Research

Summary

Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.

Rated on Published on

Unlock our full analysis with Morningstar Investor

Portfolio Holdings REQSX

  • Current Portfolio Date
  • Equity Holdings
  • Bond Holdings
  • Other Holdings
  • % Assets in Top 10 Holdings 19.5
Top 10 Holdings
% Portfolio Weight
Market Value USD
Sector

E-mini S&P 500 Future Sept 24

5.92 11.9 Mil

U.S. Cash Management Fund

5.72 11.5 Mil
Cash and Equivalents

JPMorgan Chase & Co

2.39 4.8 Mil
Financial Services

Berkshire Hathaway Inc Class B

1.65 3.3 Mil
Financial Services

CVS Health Corp

1.53 3.1 Mil
Healthcare

Citigroup Inc

1.49 3.0 Mil
Financial Services

Merck & Co Inc

1.48 3.0 Mil
Healthcare

Wells Fargo & Co

1.36 2.7 Mil
Financial Services

Philip Morris International Inc

1.36 2.7 Mil
Consumer Defensive

Medtronic PLC

1.21 2.4 Mil
Healthcare